Table 1

MPO-deficient donors

DonorCountryGenotypeReference
Germany c.2031-2A>C/c.2031-2A>C 38 
USA c.2031-2A>C/c.2031-2A>C  
France c.1555-1568del14, p.M519PfsX21/c.1907C>T, p.T636M and c.2031-2A>C 27 
France c.995C>T, p.A332V/c. 2031-2A>C 27 
Luxembourg c.752T>C, p.M251T/c.1705C>T, p.R569W  
USA c.929T>C, p.M251T/g.8089C>T, pR569W 39 
DonorCountryGenotypeReference
Germany c.2031-2A>C/c.2031-2A>C 38 
USA c.2031-2A>C/c.2031-2A>C  
France c.1555-1568del14, p.M519PfsX21/c.1907C>T, p.T636M and c.2031-2A>C 27 
France c.995C>T, p.A332V/c. 2031-2A>C 27 
Luxembourg c.752T>C, p.M251T/c.1705C>T, p.R569W  
USA c.929T>C, p.M251T/g.8089C>T, pR569W 39 

Nomenclature for genotypes is according to den Dunnen and Antonarakis.40  The c.2031-2A>C splice mutation in donors 1-3, and the frameshift deletion in donor 3 consistently generate null alleles, whereas the missense mutations in donors 4-6 allow for residual MPO activity.

or Create an Account

Close Modal
Close Modal